It sounds great in principle: Buy multi-bagger stocks that deliver life-changing returns. But is it possible in practice? Investor Christopher Mayer wrote a...
Archive - 10 months ago
Stocks with moonshot potential are drawing attention amidst the current bullishness in the stock market. Despite the latest inflation reports pointing to a...
The market might be at an all-time high, but that doesn’t mean that every stock out there is a buy. The reality is that it remains a stock pickers world and...
The United States housing market is heading into its busiest season, with several real estate stocks poised to gain from falling mortgage rates. With investors...
While you might not personally be a fan of digitally immersive experiences, the industry is taking over and that means virtual reality stocks offer a...
With inflation these days, you might think you’re only going to receive junk when it comes to stocks under $20. And certainly, there’s a lot of smelly stuff...
While the celebrated top-tier tech stocks can practically rest on their laurels, an elite few are pushing the narrative of innovation even further. For...
In an era of fast technological innovation and fluctuating market landscapes, spotting the next big investment opportunity is like traversing a maze of...
Dividend stocks are optimal for investors who want cash flow and don’t want to deal with real estate. These stocks pay dividends frequently, raise them each...
U.S. tech equities sustained a jaw-breaking rally in 2023, with the Nasdaq beating all other indices, accruing a more than 43% return. Big tech and a number of...
The slump in the hydrogen space, marked by a 20% year-to-date slide in the Global X Hydrogen ETF (NASDAQ:HYDR), underscores a market teeming with undervalued...
The market is overlooking many stocks that could benefit from the proliferation of AI over the longer term. There are companies using AI to solve real-world...
Monte Rosa Therapeutics (NASDAQ:GLUE) just reported results for the fourth quarter of 2023. Monte Rosa Therapeutics reported earnings per share of -58 cents...
RumbleON (NASDAQ:RMBL) just reported results for the fourth quarter of 2023. RumbleON reported earnings per share of -$7.81. This was below the analyst...
Century Therapeutics (NASDAQ:IPSC) just reported results for the fourth quarter of 2023. Century Therapeutics reported earnings per share of -65 cents. This...
While the rally of Bitcoin (BTC-USD) and the broader crypto market is well underway (and far from over, in my opinion), there are some Web3 cryptos that every...
The travel industry has been in a post-pandemic boom, but the wind may be going out of its sails. Online travel agent (OTA) Expedia (NASDAQ:EXPE) surprised the...
Despite the roaring market and economy, the magnitude of plastic debt forces an uncomfortable and cynical discussion: stocks benefiting from credit card...
As we navigate into a new era of technological innovation, the market for drone stocks is rapidly expanding. These stocks represent businesses effectively...
Investors may not want to write metaverse stocks off just yet. According to Market.us, the market could be worth about $2.3 trillion by 2032. All thanks to...